Target-based Classification of Drugs

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

     Remark
 G Protein-coupled receptors
 
 Cytokine receptors
 
 Nuclear receptors
 
 Ion channels
 
 Transporters
   ABC transporters
   Solute carrier family
     SLC5
     SLC6
     SLC9
     SLC12
       SLC12A1 [HSA:6557] [KO:K14425]
         Piretanide [ATC:C03CA03]
         Etacrynic acid [ATC:C03CC01]
         Muzolimine [ATC:C03CD01]
         Furosemide [ATC:C03CA01]
         Bumetanide [ATC:C03CA02]
         Torasemide [ATC:C03CA04]
           D00382  Torasemide (JAN/INN); Torsemide (USP)
           D08619  Torasemide sodium
Inhibitor
Inhibitor
         Etacrynic acid [ATC:C03CC01]
         Alilusem
         Azosemide
         Tripamide
       SLC12A2 [HSA:6558] [KO:K10951] [TC:2.A.30.3.1]
         Furosemide [ATC:C03CA01]
         Bumetanide [ATC:C03CA02]
         Torasemide [ATC:C03CA04]
           D00382  Torasemide (JAN/INN); Torsemide (USP)
           D08619  Torasemide sodium
Inhibitor
Inhibitor
         Etacrynic acid [ATC:C03CC01]
         Alilusem
       SLC12A3 [HSA:6559] [KO:K14426] [TC:2.A.30.4.2]
     SLC22
     SLC29
   Major facilitator superfamily
   Others
 
 Enzymes
 
 Protein kinases
 
 Cytokines
 
 Others

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: July 9, 2014

» Japanese version